WuXi AppTec Co. Ltd (WX8) - Total Liabilities

Latest as of March 2026: €22.64 Billion EUR ≈ $26.47 Billion USD

Based on the latest financial reports, WuXi AppTec Co. Ltd (WX8) has total liabilities worth €22.64 Billion EUR (≈ $26.47 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is WuXi AppTec Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.

WuXi AppTec Co. Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how WuXi AppTec Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See WuXi AppTec Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

WuXi AppTec Co. Ltd Competitors by Total Liabilities

The table below lists competitors of WuXi AppTec Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Renaissancere Holdings Ltd
NYSE:RNR
USA $35.16 Billion
MAPFRE S.A.ADR 2 / EO-10
F:CMA
Germany €48.00 Billion
Texas Roadhouse Inc
NASDAQ:TXRH
USA $1.79 Billion
Innolux Corp
TW:3481
Taiwan NT$158.17 Billion
Goertek Inc
SHE:002241
China CN¥54.38 Billion
Hero MotoCorp Limited
NSE:HEROMOTOCO
India Rs116.42 Billion
Semtech Corporation
NASDAQ:SMTC
USA $865.62 Million
Embraer SA ADR
NYSE:ERJ
USA $8.59 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down WuXi AppTec Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see WuXi AppTec Co. Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.42 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.27 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how WuXi AppTec Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for WuXi AppTec Co. Ltd (2016–2025)

The table below shows the annual total liabilities of WuXi AppTec Co. Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €22.87 Billion
≈ $26.74 Billion
+7.69%
2024-12-31 €21.24 Billion
≈ $24.83 Billion
+17.01%
2023-12-31 €18.15 Billion
≈ $21.22 Billion
+2.19%
2022-12-31 €17.76 Billion
≈ $20.77 Billion
+8.51%
2021-12-31 €16.37 Billion
≈ $19.14 Billion
+20.61%
2020-12-31 €13.57 Billion
≈ $15.87 Billion
+14.74%
2019-12-31 €11.83 Billion
≈ $13.83 Billion
+162.76%
2018-12-31 €4.50 Billion
≈ $5.26 Billion
-22.94%
2017-12-31 €5.84 Billion
≈ $6.83 Billion
+29.02%
2016-12-31 €4.53 Billion
≈ $5.29 Billion
--

About WuXi AppTec Co. Ltd

F:WX8 Germany Diagnostics & Research
Market Cap
$12.01 Billion
€10.28 Billion EUR
Market Cap Rank
#1947 Global
#405 in Germany
Share Price
€20.13
Change (1 day)
+8.23%
52-Week Range
€10.60 - €20.13
All Time High
€20.13
About

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manuf… Read more